Clinical and instrumental predictors of efficacy of natalizumab therapy in the course of multiple sclerosis: a retrospective study from a single centre

Research output: Contribution to conferenceOther

Original languageEnglish
PagesS66-S67
Number of pages2
Publication statusPublished - 2013

Cite this